Home > Insider Trading > Filing (0000950170-24-026682)

Filing Details

Accession Number:: 0000950170-24-026682
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-03-05 20:28:43
Reporting Period:: 2024-03-04

Accepted Time:: 2024-03-05 20:28:43
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1521036	Lantheus Holdings Inc.	LNTH	In Vitro & In Vivo Diagnostic Substances (2835)	352318913

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1610676	Anne Mary Heino	C/O Lantheus Holdings, Inc. 201 Burlington Road, South Bldg Bedford MA 01730		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-03-04	81,169	$0.00	345,506	No	4	A	Direct
Common Stock	Disposition	2024-03-04	34,512	$64.81	310,994	No	4	S	Direct
Common Stock	Disposition	2024-03-04	59,251	$65.59	251,743	No	4	S	Direct
Common Stock	Disposition	2024-03-04	100	$66.23	251,643	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	78,980	Indirect	By Grantor Retained Annuity Trust
Common Stock	300,000	Indirect	By Grantor Retained Annuity Trust

Footnotes

The transaction reported in this Form 4 reflects additional shares of common stock issued by Lantheus Holdings, Inc. ("LNTH") to the reporting person upon the vesting of relative Total Shareholder Return PSUs that were previously granted and included in the Form 4 filed on March 8, 2021. The number of shares reported in the Form 4 reflected 100% of the target number of shares underlying the PSUs. The number of shares that actually vested under the PSUs equaled 200% of the target number of shares. Accordingly, the number of shares reported in this Form 4 reflects the difference between the number of shares that actually vested under the PSUs and the target number of shares originally included in the Form 4.
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2023.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.14 to $65.13, inclusive. The reporting person undertakes to provide to LNTH any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.14 to $66.10, inclusive. The reporting person undertakes to provide to LNTH any security holder of LNTH or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.